{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "UCH-L1",
        "Protein_Change": {
          "ref": "I",
          "alt": "M",
          "position": "93"
        },
        "variant_string_id": "UCH-L1 I93M"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The secretion of UCH-L1 is altered by the PD-associated I93M mutation.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay, linking the I93M mutation to altered secretion in PD."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The assay used is a secretion assay, which is relevant to the disease mechanism of altered secretion in PD.",
          "judgment": "Yes",
          "reasoning": "The secretion assay is applicable as it directly models the disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The paper mentions wild-type as a control but does not specify replicates.",
          "judgment": "No",
          "reasoning": "While wild-type controls are mentioned, replicates are not specified.",
          "next_step_or_outcome": "Proceed to Step 3b"
        },
        {
          "step_name": "Step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "Secretion assays are standard techniques in the field.",
          "judgment": "Yes",
          "reasoning": "The assay is a standard technique, thus validated.",
          "next_step_or_outcome": "Functional evidence strength is PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The I93M mutation shows altered secretion, a pathogenic effect, supported by a validated assay."
    },
    {
      "variant_id": {
        "Gene": "UCH-L1",
        "Protein_Change": {
          "ref": "WT",
          "alt": "WT",
          "position": "N/A"
        },
        "variant_string_id": "UCH-L1 WT"
      },
      "functional_evidence_aim": "Benign",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The disease mechanism involves altered secretion in PD.",
          "judgment": "Yes",
          "reasoning": "The mechanism is defined, relevant to the wild-type as a control."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The secretion assay is applicable to the disease mechanism.",
          "judgment": "Yes",
          "reasoning": "The assay models the disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Wild-type controls are mentioned without replicate details.",
          "judgment": "No",
          "reasoning": "Replicates not specified.",
          "next_step_or_outcome": "Proceed to Step 3b"
        },
        {
          "step_name": "Step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "Secretion assays are standard and validated.",
          "judgment": "Yes",
          "reasoning": "Standard technique validates the assay.",
          "next_step_or_outcome": "Functional evidence strength is BS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Benign",
        "strength": "BS3_supporting"
      },
      "overall_conclusion": "Wild-type UCH-L1 serves as a benign control with normal secretion, supported by a validated assay."
    }
  ]
}